Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The therapeutic strategy of lowering the pH within the colon (making it more acidic) in order to reduce the absorption of ammonia from the gut into systemic circulation. This mechanism is particularly relevant in managing conditions like hepatic encephalopathy, where elevated blood ammonia levels contribute to neurotoxicity.
Lowering colonic pH increases conversion of freely diffusible ammonia (NH₃) into ammonium ion (NH₄⁺), which is not readily absorbed across colonic mucosa. Acidification also alters colonic microbiota, favoring non-urease-producing bacteria. Some agents also act as cathartics, increasing stool water content and accelerating transit time.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colonic pH Reduction for Decreased Ammonia Absorption (Colonic pH Reduction).